Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus
Authors
Keywords
-
Journal
JOURNAL OF VIRAL HEPATITIS
Volume 22, Issue 4, Pages 427-432
Publisher
Wiley
Online
2014-09-02
DOI
10.1111/jvh.12309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- (2015) JOURNAL OF HEPATOLOGY
- Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study
- (2013) E. S. Andersen et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma
- (2013) Oliver Waidmann et al. JOURNAL OF HEPATOLOGY
- Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis
- (2013) Oliver Waidmann et al. JOURNAL OF HEPATOLOGY
- Hepatitis B Virus Surface Antigen Selectively Inhibits TLR2 Ligand-Induced IL-12 Production in Monocytes/Macrophages by Interfering with JNK Activation
- (2013) S. Wang et al. JOURNAL OF IMMUNOLOGY
- Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
- (2013) Barbara Rehermann NATURE MEDICINE
- Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure
- (2013) Hong Ye WORLD JOURNAL OF GASTROENTEROLOGY
- Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion
- (2012) Dimitra Peppa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- (2012) Patrick Marcellin et al. LANCET
- The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases
- (2011) G. Sebastiani et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection
- (2011) O. Waidmann et al. JOURNAL OF VIRAL HEPATITIS
- Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity
- (2011) P. A. Lang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Soluble CD163
- (2011) Holger J. Møller SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers
- (2010) Maurizia Rossana Brunetto et al. GASTROENTEROLOGY
- Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study)
- (2010) Francoise Degos et al. JOURNAL OF HEPATOLOGY
- Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective
- (2010) Jerzy Jaroszewicz et al. JOURNAL OF HEPATOLOGY
- Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
- (2007) Giovanna Fattovich et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now